{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:48:38Z","timestamp":1759938518096,"version":"3.40.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pathol.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T10:19:51Z","timestamp":1529662791000},"page":"565-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic granulomatous interstitial nephritis and urothelial metaplasia associated with ritonavir-boosted atazanavir: a case study and literature review"],"prefix":"10.1016","volume":"50","author":[{"given":"Gerard Joseph","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-3433","authenticated-orcid":false,"given":"Kenneth","family":"Howlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Murad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2018.01.009_bib1","first-page":"106954","article-title":"Relationships between serum levels of atazanavir and renal toxicity or lithiasis","volume":"2015","author":"Marinescu","year":"2015","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.pathol.2018.01.009_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00365548.2012.712213","article-title":"Incidence of renal toxicity in HIV-infected, antiretroviral-na\u00efve patients starting tenofovir\/emtricitabine associated with efavirenz, atazanavir\/ritonavir, or lopinavir\/ritonavir","volume":"45","author":"Calza","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.pathol.2018.01.009_bib3","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit043","article-title":"Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D Study","volume":"207","author":"Ryom","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.pathol.2018.01.009_bib4","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.7448\/IAS.17.4.19514","article-title":"A\u00a0clinically useful risk-score for chronic kidney disease in HIV infection","volume":"17","author":"Mocroft","year":"2014","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.pathol.2018.01.009_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.2011.124","article-title":"Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy","volume":"80","author":"Dauchy","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.pathol.2018.01.009_bib6","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/QAD.0b013e3282f17503","article-title":"Atazanavir crystal nephropathy","volume":"21","author":"Izzedine","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.pathol.2018.01.009_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3851\/IMP1700","article-title":"Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir","volume":"16","author":"Viglietti","year":"2011","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.pathol.2018.01.009_bib8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2169\/internalmedicine.51.7093","article-title":"Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy","volume":"51","author":"Kanzaki","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.pathol.2018.01.009_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ckj\/sfv015","article-title":"Atazanavir nephrotoxicity","volume":"8","author":"Hara","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.pathol.2018.01.009_bib10","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2012.03.005","article-title":"Quiz page June 2012: kidney failure in an HIV-positive patient","volume":"59","author":"Coelho","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pathol.2018.01.009_bib11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/jac\/dkt125","article-title":"High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients","volume":"68","author":"De Lastours","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"year":"2006","series-title":"Reyetaz: Product Information","author":"Squibb","key":"10.1016\/j.pathol.2018.01.009_bib12"},{"year":"2011","series-title":"Antiviral Drugs: From Basic Discovery Through Clinical Trials","author":"Kazmierski","key":"10.1016\/j.pathol.2018.01.009_bib13"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302517304361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302517304361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:30:03Z","timestamp":1534984203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302517304361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0031302517304361"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2018.01.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic granulomatous interstitial nephritis and urothelial metaplasia associated with ritonavir-boosted atazanavir: a case study and literature review","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}